Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · National Healthcare (NHC)

National HealthCare: COO and President Mike Ussery to retire effective December 31, 2025

Neutral Impact 3 of 5 leadership Written later

National HealthCare Corporation (NHC) said its President and Chief Operating Officer, R. Michael Ussery, intends to retire effective December 31, 2025, after notifying the company on September 23, 2025. The filing states that his decision did not involve any disagreement with the company, and he will continue in both roles until he retires. Shareholders will see a change in the company's senior operating leadership at year-end, though the filing does not name a successor.

Key points

  • Ussery has been with the company since 1980 and was appointed Chief Operating Officer on January 1, 2009, and President on January 1, 2017.
  • Retirement is effective December 31, 2025; the filing states it did not involve any disagreement with the company.
  • CEO Steve Flatt is quoted in the September 26, 2025 press release (Exhibit 99.1) thanking Ussery for his contributions.

The filing

CompanyNational Healthcare (NHC)
Form8-K, current report
Filed with the SECSep 26, 2025, 4:34 PM ET
Accession number0001437749-25-029946

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 26, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.